Biotech · Private company
SIRPant Immunotherapeutics, Inc.
Track this companyFree. Adds SIRPant Immunotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- External-beam radiotherapy (XRT)Phase 1 · Refractory Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- SIRPant-MPhase 1 · Refractory Non-Hodgkin LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's LymphomaPHASE1 · RECRUITING · started Jan 17, 2024ClinicalTrials.gov NCT05967416 · fetched Nov 12, 2026